AssayIndex
Reference

Acceptance specifications

The index applies its own acceptance specification by compound class. Every threshold is published with its reasoning and its observed failure rate. None of them is a regulatory limit and none of them is a safety threshold — a specification is a line this site drew, and these pages exist so that any PASS or FAIL chip anywhere on the site can be traced back to the decision behind it.

9 classes66 compounds6,584 records assessed
ClassCompoundsRecordsPurity ≥Water ≤Counter-ion ≤Endotoxin ≤Mass ±Observed median
Incretin analogues and co-agonists122,33897.08.012.05.01598.65
Metabolic and mitochondrial peptides538298.09.012.05.01599.27
Tissue-repair and immunomodulatory peptides101,09798.010.012.05.01599.32
Growth-hormone axis peptides131,19898.09.012.05.01599.17
Melanocortin-receptor peptides534898.58.010.05.01599.36
Hypothalamic and posterior-pituitary hormones515698.58.010.05.01599.45
Neuroactive and cognitive peptides543698.512.010.05.01599.48
Short bioregulator peptides627299.012.010.05.02099.41
Non-peptide adjuncts535798.510.012.05.01099.43

Incretin analogues and co-agonists

GLP-1, GIP and glucagon receptor agonists, including the lipidated long-acting analogues and the dual and triple co-agonists.

purity spec97.0
compounds12
ppm±15

Growth-hormone axis peptides

GHRH analogues, growth-hormone secretagogues, IGF-1 variants and conjugates.

purity spec98.0
compounds13
ppm±15

Short bioregulator peptides

Di-, tri- and tetrapeptide bioregulators, plus the thiol tripeptide glutathione and the dipeptide carnosine.

purity spec99.0
compounds6
ppm±20

Non-peptide adjuncts

Small molecules and nucleotide cofactors submitted alongside peptides. Different specification, different methods, same index.

purity spec98.5
compounds5
ppm±10